Angewandte
Chemie
Scheme 5. Synthesis of (+)-virantmycin from acyl fluoride 4: a) 10%
aqueous KOH, methanol, 20 h, RT; b) NaH, nPrSH, HMPA, 4.75 h, RT;
c) SOCl2, methanol, 1 h at ꢀ108C!3 h at reflux, 46% overall yield for
steps a–c.
favourably with the literature value [a]2D4 = + 11.28 (c = 0.125,
chloroform).[9]
Scheme 4. Synthesis of (ꢀ)-virantmycin (1) from intermediate 9:
a) N,N-dimethylaminopyridine (DMAP), pyridine, acetic anhydride, 3
days, RT; b) 1.0m tetrabutylammonium fluoride in tetrahydrofuran,
1 h, RT; c) diphenylphosphoryl azide (DPPA), N,N-dimethylaminopyri-
dine (DMAP), triethylamine, toluene, 2.25 h, reflux; then NaBH4, tetra-
hydrofuran, 12.5 h, RT, 84% overall yield for steps a–c; d) [Pd2(dba)3],
12, Cs2CO3, toluene, 6.5 h, 908C, 100%; e) 0.13m NaOH in methanol,
24 h, RT, 84%.
In conclusion, the present method provides a new route to
both enantiomers of the antiviral agent virantmycin (1). It
employs as key steps a highly enantioselective enzyme-
mediated desymmetrization and a remarkably effective intra-
molecular aryl amination of a hindered a-quaternary ali-
phatic amine. The procedure is also potentially amenable to
the preparation of analogues for the purpose of structure–
activity studies.
of aryl aminations and related Pd-catalyzed coupling reac-
tions are enhanced by weakly coordinating phosphine
ligands.[21] It is therefore possible that reductive elimination
is the rate-determining step in the present case because of the
high degree of steric hindrance associated with coupling an
ortho-substituted aryl bromide with an a-quaternary amine
derivative. The particular efficacy of BINAPFu may be
attributed to its ability to facilitate this step.
Received: July 16, 2004
Keywords: aryl amination · enzyme catalysis · esterases ·
.
natural products · total synthesis
¯
[1] S. Omura, A. Nakagawa, H. Hashimoto, R. Oiwa, Y. Iwai, A.
Hirano, N. Shibukawa, Y. Kojima, J. Antibiot. 1980, 33, 1395.
[2] A. Nakagawa, Y. Iwai, H. Hashimoto, N. Miyazaki, R. Oiwa, Y.
Takahashi, A. Hirano, N. Shibukawa, Y. Kojima, S. Omura, J.
Antibiot. 1981, 34, 1408.
[3] Y. Morimoto, K. Oda, H. Shirahama, T. Matsumoto, S. Omura,
Chem. Lett. 1988, 909.
[4] C. M. Pearce, J. K. M. Sanders, J. Chem. Soc. Perkin Trans. 1
1990, 409.
[5] Y. Morimoto, F. Matsuda, H. Shirahama, Synlett 1991, 202.
[6] a) M. L. Hill, R. A. Raphael, Tetrahedron Lett. 1986, 27, 1293;
b) M. L. Hill, R. A. Raphael, Tetrahedron 1990, 46, 4587.
[7] Y. Morimoto, F. Matsuda, H. Shirahama, Tetrahedron 1996, 52,
10609.
[8] H. Steinhagen, E. J. Corey, Org. Lett. 1999, 1, 823.
[9] Y. Morimoto, H. Shirahama, Tetrahedron 1996, 52, 10631.
[10] M. Ori, N. Toda, K. Takami, K. Tago, H. Kogen, Angew. Chem.
2003, 115, 2644; Angew. Chem. Int. Ed. 2003, 42, 2540.
[11] a) T. G. Back, R. J. Bethell, M. Parvez, D. Wehrli, J. Org. Chem.
1998, 63, 7908; b) A. N. De Silva, C. L. Francis, A. D. Ward,
Aust. J. Chem. 1993, 46, 1657.
Deacetylation and concomitant deformylation of tetrahy-
droquinoline 13 provided the free alcohol 14, which was
converted into (ꢀ)-1 by the same method used previously by
Morimoto and Shirahama[9] in their synthesis of (+)-1
(Scheme 4). The product displayed NMR spectra consistent
¯
¯
with the literature[4,6,9] and gave a specific rotation [a]2D0
=
ꢀ118 (c = 0.13, chloroform) that compared favorably with
that reported for the natural product: [a]2D4 = ꢀ11.18 (c =
0.175, chloroform).[9]
Finally, acyl fluoride 4 was converted into the unnatural
antipode (+)-1 by a similar process (Scheme 5), except that
the aromatic and aliphatic ester moieties of 15 were converted
to the free carboxylic acids in 16 by saponification of the
former and dealkylation with sodium propanethiolate of the
latter, followed by selective reesterification of the aromatic
carboxylic acid and Curtius rearrangement of the remaining
aliphatic acid (Scheme 5). Completion of the synthesis was
achieved as in the case of (ꢀ)-1. The NMR spectra of the
product were identical to those of (ꢀ)-1 and the optical
rotation data [a]2D0 = + 138 (c = 0.14, chloroform), compared
[12] a) For a general review, see: H. G. Davies, R. H. Green, D. R.
Kelly, S. M. Roberts, Biotransformations in Preparative Organic
Chemistry, Academic Press, London, 1989, chap. 2; b) F. Björk-
Angew. Chem. Int. Ed. 2004, 43, 6493 –6496
ꢀ 2004 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
6495